Beta2-adrenergic receptors — Drug Target

All drugs that target Beta2-adrenergic receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Long-acting beta2-adrenergic agonist (LABA)

Marketed (1)

• Salmeterol 50 mcg via DISKUS · GlaxoSmithKline · Long-acting beta2-adrenergic agonist (LABA) · Respiratory
  Salmeterol is a long-acting beta2-adrenergic agonist that relaxes bronchial smooth muscle to improve airflow.